0000788611
false
0000788611
2022-02-10
2022-02-10
0000788611
SGLB:CommonStockParValue0.001PerShareMember
2022-02-10
2022-02-10
0000788611
SGLB:WarrantsToPurchaseCommonStockParValue0.001PerShareMember
2022-02-10
2022-02-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 10, 2022
SIGMA
LABS, INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
|
001-38015
|
|
27-1865814
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
3900
Paseo del Sol
Santa
Fe, New Mexico 87507
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (505) 438-2576
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
☐
|
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
☐
|
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
|
Common Stock, par value
$0.001 per share
|
|
SGLB
|
|
The NASDAQ Stock Market
LLC
|
|
Warrants to Purchase Common
Stock, par value $0.001 per share
|
|
SGLBW
|
|
The NASDAQ Stock Market
LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On
February 10, 2022, Sigma Labs, Inc. (the “Company”) issued a press release regarding the upcoming expiration, delisting and
deregistration of the Company’s outstanding warrants to purchase common stock (Nasdaq: SGLBW), a copy of which is attached hereto
as Exhibit 99.1 and incorporated herein by reference.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
Date: February 10, 2022
|
SIGMA LABS, INC.
|
|
|
|
|
|
|
By:
|
/s/ Mark
K. Ruport
|
|
|
Name:
|
Mark K. Ruport
|
|
|
Title:
|
President and Chief Executive Officer
|
Exhibit 99.1
Sigma
Labs Announces Expiration of Warrants
SANTA
FE, NM – February 10, 2022 – Sigma Labs, Inc. (Nasdaq: SGLB) (the “Company”), a leading developer
of quality assurance software to the commercial 3D printing industry, announced today that the Company’s warrants to purchase common
stock issued on February 21, 2017 (NASDAQ: SGLBW) (the “Warrants”) will expire in accordance with their terms as of 5:00
p.m. EST, on February 22, 2022. The Company is informed by the Nasdaq Stock Market LLC (“Nasdaq”) that trading of
the Warrants on Nasdaq will be suspended on February 17, 2022. The exercise price for one share of the Company’s common stock under
the Warrants is $40.00. On February 9, 2022, the last reported sale price of the Company’s common stock was $2.42 per share.
The
Company also is informed that Nasdaq intends to file a Form 25 on behalf of the Company with the Securities and Exchange Commission on
February 17, 2022 to effect the delisting of the Warrants from Nasdaq and the deregistration of the Warrants under Section 12(b) of the
Securities Exchange Act of 1934, as amended.
The
listing of the Company’s common stock (Nasdaq: SGLB) will not be affected by the expiration and delisting of the Warrants.
About
Sigma Labs
Sigma
Labs Inc. is a leading provider of in-process quality assurance (IPQA™) software to the additive manufacturing industry. Sigma
Labs specializes in the development and commercialization of real-time monitoring and analytics solutions known as PrintRite3D® for
3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the
manufacturing process, enabling significant cost-savings and production efficiencies. Sigma Labs believes its software product will be
a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.sigmalabsinc.com.
Contacts:
Investor
Contact:
Chris
Tyson
Executive
Vice President
MZ
Group - MZ North America
949-491-8235
SGLB@mzgroup.us
www.mzgroup.us
Company
Contact:
Steven
Gersten
Sigma
Internal IR
813-334-9745
investors@sigmalabsinc.com